Glanbia PLC (GL9)

Currency in EUR
12.630
+0.030(+0.24%)
Closed·
Showing Glanbia PLC historical data. For real-time data please try another search
Day's Range
12.61012.790
52 wk Range
9.20019.200
Key Statistics
Prev. Close
12.67
Open
12.64
Day's Range
12.61-12.79
52 wk Range
9.2-19.2
Volume
114.02K
Average Volume (3m)
685.46K
1-Year Change
-30.22%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Glanbia PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Glanbia PLC Company Profile

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; and provision of business services and management solutions, weight management, flavor solutions, and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Employees
5791
Market
Ireland

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.000

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.63%
Dividend Yield
3.05%
Industry Median 1.75%
Annualised payout
0.39
Paid unevenly
5-Years Growth
+7.92%
Growth Streak

Earnings

Latest Release
Mar 18, 2025
EPS / Forecast
0.08 / --
Revenue / Forecast
2.02B / --
EPS Revisions
Last 90 days

GL9 Income Statement

People Also Watch

12.900
REP
-0.54%
3.1850
SABE
+2.08%
14.58
JCDX
+0.48%
70.3600
PRY
+1.97%
59.400
ACS
+1.37%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.